Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph
FDA issued an advance notice of proposed rulemaking to establish a monograph for OTC antigingivitis/antiplaque drug products, potentially reclassifying some cosmetic oral care products as drugs, requiring FDA registration, drug listing, and compliance with drug GMPs.
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Indie beauty brands, contract manufacturers, private-label makers, importers/distributors of oral care products making antigingivitis/antiplaque claims. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Comment period ends 90 days after publication in Federal Register (publication date May 29, 2003).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA is proposing to establish a monograph that would define conditions for OTC antigingivitis/antiplaque drug products, potentially reclassifying products currently marketed as cosmetics with drug claims.
Who it affects
Indie beauty brands, contract manufacturers, private-label makers, importers/distributors of oral care products making antigingivitis/antiplaque claims.
What you must do
Review product claims and formulations to determine if they fall under the proposed monograph; prepare for potential drug registration and GMP compliance.
Deadline
Comment period ends 90 days after publication in Federal Register (publication date May 29, 2003).
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- New Jersey bans some products with toxic PFAS chemicals. Here’s what to know - WHYY
- Implementing MoCRA: FDA Releases New Draft Guidances on Insanitary Conditions for Tattoo Ink and Cosmetic Product Registration & Listing - Food and Drug Law Institute (FDLI)
- France bans PFAS in cosmetics – COSlaw.eu - Guiding through EU Cosmetics Regulations - COSlaw.eu
- Illinois Governor Signs Bill Banning Intentionally Added PFAS in Certain Consumer Products and Requiring IEPA to Prepare Report on Fluoropolymers by August 1, 2027 - Bergeson & Campbell
- FDA Final Guidance on Cosmetic Facility Registration and Product Listing: Take Two - ArentFox Schiff